Ann: Lumos completes $4.75m Placement and launches SPP, page-77

Trading high of 17.5c, CR at 7c, vwap for last 7 days of around 9c.

I can see this rebounding pretty quickly to the 9c range with an announcement of using money to accelerate towards production after FDA approval.

With total assets from 2022 of around $54m, shareholder equity of $26m, and having spent 10s of millions over the years to get us to this stage, the soon to be $33m mc with $9m in cash at 7c and an EV of $24m, is sitting around the equity value before the progress towards selling our products.

I see this as a first step towards continual growth, as long as we start to see increased revenue to offset any further research and development costs.

GLTAH